No significant difference in the primary outcome was observed in the study (3.7% radial group vs 4.0% femoral group, p = 0.50). There was a significant reduction in major vascular complications in ...

The RIVAL trial demonstrates no significant difference in the primary end point between radial and femoral access, but major vascular complications are reduced significantly in radial group.